LIFESTYLE MODIFICATION AND PHARMACOTHERAPY IN BREAST CANCER: A COMPREHENSIVE REVIEW

Breast cancer is the most commonly diagnosed cancer among women worldwide and remains a leading cause of cancer-related mortality despite significant advances in diagnosis and treatment. The increasing global burden of breast cancer highlights the importance of a comprehensive management approach that integrates evidence-based pharmacotherapy with healthy lifestyle modifications. Pharmacological treatment includes surgery-supported systemic therapies such as chemotherapy, endocrine therapy, targeted therapy, immunotherapy, and supportive care, each selected according to tumour subtype, stage, and individual patient characteristics. These therapies have substantially improved survival outcomes; however, they are often associated with adverse effects that may affect patients' quality of life and treatment adherence. Lifestyle modification has emerged as an importantcomplementary strategy in breast cancer prevention, treatment, and survivorship. Regular physical activity, a balanced diet rich in fruits, vegetables, and whole grains, maintenance of a healthy body weight, smoking cessation, limited alcohol consumption, adequate sleep, stress management, and psychosocial support have been shown to reduce the risk of recurrence, improve treatment tolerance, minimise therapy-related complications, and enhance overall well-being. Growing scientific evidence also suggests that these interventions positively influence metabolic, inflammatory, and hormonal pathways involved in breast cancer progression. This review summarises the current evidence on the role of lifestyle modification alongside pharmacotherapy in breast cancer management. It discusses the mechanisms, therapeutic benefits, limitations, and recent advances in treatment, while emphasising the importance of a multidisciplinary and patient-centred approach. Integrating pharmacological therapies with sustainable lifestyle interventions can optimise clinical outcomes, improve quality of life, and contribute to long-term survival among breast cancer patients. This review aims to provide healthcare professionals and researchers with a comprehensive overview of current strategies and future directions in breast cancer management.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-09-01
DOI
https://doi.org/10.5281/zenodo.22158893
Primary Topic
Cancer Risks and Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

LIFESTYLE MODIFICATION AND PHARMACOTHERAPY IN BREAST CANCER: A COMPREHENSIVE REVIEW

1*Ms. Shubhangi A. Hingmire, 2Dr. Kelgaokar Prajakta, 1Ms. Sakshi S. Hindole, 1Ms. Runal R. Surudwad, 1Ms. Jyotsna M. Hake
Zenodo (CERN European Organization for Nuclear Research)
Cancer Risks and Factors
article

LIFESTYLE MODIFICATION AND PHARMACOTHERAPY IN BREAST CANCER: A COMPREHENSIVE REVIEW

1*Ms. Shubhangi A. Hingmire, 2Dr. Kelgaokar Prajakta, 1Ms. Sakshi S. Hindole, 1Ms. Runal R. Surudwad, 1Ms. Jyotsna M. Hake
article en

Abstract

Breast cancer is the most commonly diagnosed cancer among women worldwide and remains a leading cause of cancer-related mortality despite significant advances in diagnosis and treatment. The increasing global burden of breast cancer highlights the importance of a comprehensive management approach that integrates evidence-based pharmacotherapy with healthy lifestyle modifications. Pharmacological treatment includes surgery-supported systemic therapies such as chemotherapy, endocrine therapy, targeted therapy, immunotherapy, and supportive care, each selected according to tumour subtype, stage, and individual patient characteristics. These therapies have substantially improved survival outcomes; however, they are often associated with adverse effects that may affect patients' quality of life and treatment adherence. Lifestyle modification has emerged as an importantcomplementary strategy in breast cancer prevention, treatment, and survivorship. Regular physical activity, a balanced diet rich in fruits, vegetables, and whole grains, maintenance of a healthy body weight, smoking cessation, limited alcohol consumption, adequate sleep, stress management, and psychosocial support have been shown to reduce the risk of recurrence, improve treatment tolerance, minimise therapy-related complications, and enhance overall well-being. Growing scientific evidence also suggests that these interventions positively influence metabolic, inflammatory, and hormonal pathways involved in breast cancer progression. This review summarises the current evidence on the role of lifestyle modification alongside pharmacotherapy in breast cancer management. It discusses the mechanisms, therapeutic benefits, limitations, and recent advances in treatment, while emphasising the importance of a multidisciplinary and patient-centred approach. Integrating pharmacological therapies with sustainable lifestyle interventions can optimise clinical outcomes, improve quality of life, and contribute to long-term survival among breast cancer patients. This review aims to provide healthcare professionals and researchers with a comprehensive overview of current strategies and future directions in breast cancer management.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 13%
Cancer Risks and Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.